Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
31 rows where has_cryoEM = 1, surface_class = "A2_pm_peripheral" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: evidence_priority, pdb_count_total, aptamer_count_pubmed, opentargets_top_disease_name
tier 1
- Tier 1.5 · 31 ✖
surface_class 1
- A2_pm_peripheral · 31 ✖
has_structure 1
- 1 31
has_cryoEM 1
- 1 · 31 ✖
has_activation_state_pdb_pair 1
- 0 31
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P31040 | SDHA | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Tier 1.5 | 0.785 | 1 | A2_pm_peripheral | 4 | 93.94 | 1 | 0 | 0 | 0 | 1 | mitochondrial complex II deficiency, nuclear type 1 | 0.815589203208636 | |||
| Q12840 | KIF5A | Kinesin heavy chain isoform 5A | Tier 1.5 | 0.781 | 1 | A2_pm_peripheral | 4 | 75.31 | 1 | 0 | 0 | 0 | 1 | hereditary spastic paraplegia 10 | 0.8029405627392309 | |||
| O00330 | PDHX | Pyruvate dehydrogenase protein X component, mitochondrial | Tier 1.5 | 0.779 | 1 | A2_pm_peripheral | 5 | 77.31 | 1 | 0 | 0 | 0 | 1 | pyruvate dehydrogenase E3-binding protein deficiency | 0.7957753555992844 | |||
| Q9NQG7 | HPS4 | BLOC-3 complex member HPS4 | Tier 1.5 | 0.779 | 1 | A2_pm_peripheral | 1 | 61.66 | 1 | 0 | 0 | 0 | 1 | Hermansky-Pudlak syndrome with pulmonary fibrosis | 0.7967575753847002 | |||
| O00468 | AGRN | Agrin | Tier 1.5 | 0.777 | 1 | A2_pm_peripheral | 1 | 68.81 | 1 | 0 | 0 | 0 | 1 | congenital myasthenic syndrome 8 | 0.7912009864338403 | |||
| Q9ULC3 | RAB23 | Ras-related protein Rab-23 | Tier 1.5 | 0.776 | 1 | A2_pm_peripheral | 6 | 79.56 | 1 | 0 | 1 | 1 | 23618401 | 1 | RAB23-related Carpenter syndrome | 0.7879955689930709 | ||
| P32121 | ARRB2 | Beta-arrestin-2 | Tier 1.5 | 0.719 | 1 | A2_pm_peripheral | 1 | 83.81 | 1 | 0 | 1 | 4 | 24736311, 40652239, 29054528 | 1 | cancer | 0.5962458729823639 | ||
| O15511 | ARPC5 | Actin-related protein 2/3 complex subunit 5 | Tier 1.5 | 0.699 | 1 | A2_pm_peripheral | 2 | 92.19 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5305805352966168 | |||
| P30154 | PPP2R1B | Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform | Tier 1.5 | 0.699 | 1 | A2_pm_peripheral | 1 | 92.81 | 1 | 0 | 0 | 0 | 1 | cancer | 0.5305484520119053 | |||
| O00762 | UBE2C | Ubiquitin-conjugating enzyme E2 C | Tier 1.5 | 0.689 | 1 | A2_pm_peripheral | 9 | 88.56 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.49682303083942114 | |||
| P31948 | STIP1 | Stress-induced-phosphoprotein 1 | Tier 1.5 | 0.689 | 1 | A2_pm_peripheral | 8 | 89.75 | 1 | 0 | 1 | 7 | 41406518, 38012811, 34831332, 32614006, 27681499, 24654750, 24013070 | 1 | neurodegenerative disease | 0.4967711525222825 | ||
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase 2 | Tier 1.5 | 0.688 | 1 | A2_pm_peripheral | 17 | 92.88 | 1 | 0 | 1 | 1 | 35980938 | 1 | neurodegenerative disease | 0.49455272812698803 | ||
| P63098 | PPP3R1 | Calcineurin subunit B type 1 | Tier 1.5 | 0.673 | 1 | A2_pm_peripheral | 21 | 91.12 | 1 | 0 | 1 | 2 | 39263947 | 1 | Abnormality of the skeletal system | 0.44389060142742937 | ||
| Q9H0A8 | COMMD4 | COMM domain-containing protein 4 | Tier 1.5 | 0.663 | 1 | A2_pm_peripheral | 4 | 80.75 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4109063598016124 | |||
| Q00536 | CDK16 | Cyclin-dependent kinase 16 | Tier 1.5 | 0.652 | 1 | A2_pm_peripheral | 3 | 71.94 | 1 | 0 | 0 | 0 | 1 | Intellectual disability | 0.3718454818549898 | |||
| O60551 | NMT2 | Glycylpeptide N-tetradecanoyltransferase 2 | Tier 1.5 | 0.651 | 1 | A2_pm_peripheral | 3 | 80.88 | 1 | 0 | 0 | 0 | 1 | HIV infection | 0.37004182950305764 | |||
| P50748 | KNTC1 | Kinetochore-associated protein 1 | Tier 1.5 | 0.64 | 1 | A2_pm_peripheral | 1 | 71.5 | 1 | 0 | 0 | 0 | 1 | osteoarthritis, knee | 0.3323628521281481 | |||
| Q9UNZ2 | NSFL1C | NSFL1 cofactor p47 | Tier 1.5 | 0.638 | 1 | A2_pm_peripheral | 3 | 74.06 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.3262410536701536 | |||
| P49459 | UBE2A | Ubiquitin-conjugating enzyme E2 A | Tier 1.5 | 0.626 | 1 | A2_pm_peripheral | 5 | 94.12 | 1 | 0 | 0 | 0 | 0 | syndromic X-linked intellectual disability Nascimento type | 0.7867796040270276 | |||
| A7E2V4 | ZSWIM8 | Zinc finger SWIM domain-containing protein 8 | Tier 1.5 | 0.625 | 1 | A2_pm_peripheral | 1 | 61.94 | 1 | 0 | 0 | 0 | 1 | aortic stenosis | 0.28253434569668473 | |||
| P15104 | GLUL | Glutamine synthetase | Tier 1.5 | 0.622 | 1 | A2_pm_peripheral | 12 | 97.5 | 1 | 0 | 1 | 4 | 39533430, 30085248, 21282981 | 0 | congenital brain dysgenesis due to glutamine synthetase deficiency | 0.7733687702812198 | ||
| P50552 | VASP | Vasodilator-stimulated phosphoprotein | Tier 1.5 | 0.604 | 1 | A2_pm_peripheral | 11 | 69.75 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.21494427179372053 | |||
| Q8IUC6 | TICAM1 | TIR domain-containing adapter molecule 1 | Tier 1.5 | 0.581 | 1 | A2_pm_peripheral | 8 | 62.78 | 1 | 0 | 0 | 0 | 0 | Herpetic encephalitis | 0.6364986386236531 | |||
| P26022 | PTX3 | Pentraxin-related protein PTX3 | Tier 1.5 | 0.577 | 1 | A2_pm_peripheral | 9 | 76.75 | 1 | 0 | 0 | 0 | 1 | polycystic ovary syndrome | 0.12287624125782433 | |||
| P55010 | EIF5 | Eukaryotic translation initiation factor 5 | Tier 1.5 | 0.577 | 1 | A2_pm_peripheral | 6 | 73.19 | 1 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.12225325872435809 | |||
| P56597 | NME5 | Nucleoside diphosphate kinase 5 | Tier 1.5 | 0.563 | 1 | A2_pm_peripheral | 1 | 90.06 | 1 | 0 | 0 | 0 | 0 | ciliary dyskinesia, primary, 48, without situs inversus | 0.5766985649142533 | |||
| Q9GZN1 | ACTR6 | Actin-related protein 6 | Tier 1.5 | 0.533 | 1 | A2_pm_peripheral | 9 | 94.31 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.4758409073452339 | |||
| Q5VTH2 | CFAP126 | Protein Flattop | Tier 1.5 | 0.51 | 1 | A2_pm_peripheral | 2 | 72.62 | 1 | 0 | 0 | 0 | 0 | hereditary pheochromocytoma-paraganglioma | 0.4009925718465981 | |||
| O75182 | SIN3B | Paired amphipathic helix protein Sin3b | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 4 | 68.0 | 1 | 0 | 1 | 2 | 16914451 | 0 | syndromic intellectual disability | 0.37050380432141355 | ||
| P55089 | UCN | Urocortin | Tier 1.5 | 0.469 | 1 | A2_pm_peripheral | 6 | 68.25 | 1 | 0 | 1 | 3 | 30221506, 26488412, 23248006 | 0 | neurodegenerative disease | 0.26311734927710556 | ||
| Q86UC2 | RSPH3 | Radial spoke head protein 3 homolog | Tier 1.5 | 0.39 | 1 | A2_pm_peripheral | 1 | 64.62 | 1 | 0 | 0 | 0 | 0 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;